Lifecore Biomedical Q4 Earnings Call Highlights

On profitability, gross profit in the quarter was $12.8 million , compared with $11.1 million in the prior comparable quarter. Over the seven-month transition period, gross margin improved to 31% from 26% a year earlier, which Lake said was primarily driven by higher HA volume and better manufacturing absorption.Chief Financial Officer Ryan Lake attributed the quarterly revenue increase primarily to a $5.6 million increase in hyaluronic acid (HA) manufacturing , driven mainly by the timing of revenue tied t ...